【摘要】 医学检验结果同质化管理是实现检验结果互认的基础，也是促进医疗服务共享机制、增强医疗机构协同性的重要举措。疾病变化的复杂性和时效性，检测设备性能和检测流程质量管理的差异性，形态学检验的难点等问题使同质化管理在实施过程中可能存在一系列医疗风险。通过对检测前、中、后各阶段中可能存在的主要问题进行分析，及时采取预防措施，可降低或消除影响血液体液检验同质化的风险。文章结合复旦大学附属华山医院基于专业特色充分利用人工智能，对不同医疗机构和同一医疗机构多院区同质化管理的实践进行阐述和分析。更多还原

【Abstract】 The homogenization management of medical determination results is a basis for achieving mutual recognition of determination results and an important initiative to promote the sharing mechanism of medical services and enhance synergy among medical institutions. Due to the complexity and timeliness of disease changes,the differences in the performance of determination equipment and quality management of determination processes,as well as the difficulties of morphological determination,a series of medical risks may be brought about during the implementation of homogenization management. By analyzing the main problems that may exist in the pre-,mid-and post-analysis phases and the impact on determination results,preventive measures are analyzed to reduce or eliminate the risk factors affecting the homogenization of blood and body fluid. Combined with the professional characteristic technology,the clinical classic case practice of homogenization management in different medical institutions and multi-hospital areas is elaborated and analyzed.更多还原